Gerber Y. Weston S.A. Redfield M.M. et al.

A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010.

JAMA Intern Med. 2015; 175: 996-1004View in Article Scopus (377) PubMed Crossref Google ScholarSimonneau G. Montani D. Celermajer D.S. et al.

Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Eur Respir J. 2019; 53: 1801913View in Article Scopus (1533) PubMed Crossref Google ScholarStrange G. Playford D. Stewart S. et al.

Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort.

Heart. 2012; 98: 1805-1811View in Article Scopus (174) PubMed Crossref Google ScholarVachiery J.L. Adir Y. Barbera J.A. et al.

Pulmonary hypertension due to left heart diseases.

J Am Coll Cardiol. 2013; 62: D100-D108View in Article Scopus (454) PubMed Crossref Google ScholarLam C.S. Roger V.L. Rodeheffer R.J. et al.

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.

J Am Coll Cardiol. 2009; 53: 1119-1126View in Article Scopus (744) PubMed Crossref Google ScholarGalie N. Channick R.N. Frantz R.P. et al.

Risk stratification and medical therapy of pulmonary arterial hypertension.

Eur Respir J. 2019; 53: 1801889View in Article Scopus (375) PubMed Crossref Google ScholarVachiery J.L. Tedford R.J. Rosenkranz S. et al.

Pulmonary hypertension due to left heart disease.

Eur Respir J. 2019; 53: 1801897View in Article Scopus (238) PubMed Crossref Google ScholarKim N.H. Delcroix M. Jais X. et al.

Chronic thromboembolic pulmonary hypertension.

Eur Respir J. 2019; 53: 1-10View in Article Scopus (270) Crossref Google ScholarWaxman A. Restrepo-Jaramillo R. Thenappan T. et al.

Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease.

N Engl J Med. 2021; 384: 325-334View in Article Scopus (82) PubMed Crossref Google ScholarKovacs G. Berghold A. Scheidl S. et al.

Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.

Eur Respir J. 2009; 34: 888-894View in Article Scopus (661) PubMed Crossref Google ScholarCaravita S. Dewachter C. Soranna D. et al.

Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.

Eur Respir J. 2018; 51: 1702427View in Article Scopus (17) PubMed Crossref Google ScholarVanderpool R.R. Saul M. Nouraie M. et al.

Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction.

JAMA Cardiol. 2018; 3: 298-306View in Article Scopus (88) PubMed Crossref Google ScholarGalie N. Humbert M. Vachiery J.L. et al.

2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT).

Eur Respir J. 2015; 46: 903-975View in Article Scopus (1891) PubMed Crossref Google ScholarShah A.M. Claggett B. Sweitzer N.K. et al.

Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Circ Heart Fail. 2014; 7: 740-751View in Article Scopus (171) PubMed Crossref Google ScholarSimonneau G. Galie N. Rubin L.J. et al.

Clinical classification of pulmonary hypertension.

J Am Coll Cardiol. 2004; 43: 5S-12SView in Article Scopus (1533) PubMed Crossref Google ScholarLam C.S. Borlaug B.A. Kane G.C. et al.

Age-associated increases in pulmonary artery systolic pressure in the general population.

Circulation. 2009; 119: 2663-2670View in Article Scopus (316) PubMed Crossref Google ScholarKjaergaard J. Akkan D. Iversen K.K. et al.

Prognostic importance of pulmonary hypertension in patients with heart failure.

Am J Cardiol. 2007; 99: 1146-1150View in Article Scopus (177) PubMed Abstract Full Text Full Text PDF Google ScholarMohammed S.F. Hussain I. AbouEzzeddine O.F. et al.

Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Circulation. 2014; 130: 2310-2320View in Article Scopus (302) PubMed Crossref Google ScholarMelenovsky V. Hwang S.J. Lin G. et al.

Right heart dysfunction in heart failure with preserved ejection fraction.

Eur Heart J. 2014; 35: 3452-3462View in Article Scopus (377) PubMed Crossref Google ScholarMcLaughlin V.V. Shah S.J. Souza R. et al.

Management of pulmonary arterial hypertension.

J Am Coll Cardiol. 2015; 65: 1976-1997View in Article PubMed Crossref Google ScholarFarber H.W. Foreman A.J. Miller D.P. et al.

REVEAL Registry: correlation of right heart catheterization and echocardiography in patients with pulmonary arterial hypertension.

Congest Heart Fail. 2011; 17: 56-64View in Article Scopus (74) PubMed Crossref Google ScholarRaza F. Dillane C. Mirza A. et al.

Differences in right ventricular morphology, not function, indicate the nature of increased afterload in pulmonary hypertensive subjects with normal left ventricular function.

Echocardiography. 2017; 34: 1584-1592View in Article Scopus (10) Crossref Google ScholarArkles J.S. Opotowsky A.R. Ojeda J. et al.

Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension.

Am J Respir Crit Care Med. 2011; 183: 268-276View in Article Scopus (144) PubMed Crossref Google ScholarOpotowsky A.R. Ojeda J. Rogers F. et al.

A simple echocardiographic prediction rule for hemodynamics in pulmonary hypertension.

Circ Cardiovasc Imaging. 2012; 5: 765-775View in Article Scopus (90) PubMed Crossref Google ScholarMoraes D.L. Colucci W.S. Givertz M.M.

Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management.

Circulation. 2000; 102: 1718-1723View in Article PubMed Crossref Google ScholarGuazzi M. Vicenzi M. Arena R. et al.

Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.

Circulation. 2011; 124: 164-174View in Article Scopus (425) PubMed Crossref Google ScholarRedfield M.M. Chen H.H. Borlaug B.A. et al.

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

JAMA. 2013; 309: 1268-1277View in Article Scopus (840) PubMed Crossref Google ScholarHoendermis E.S. Liu L.C. Hummel Y.M. et al.

Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.

Eur Heart J. 2015; 36: 2565-2573View in Article Scopus (205) PubMed Crossref Google ScholarPieske B. Maggioni A.P. Lam C.S.P. et al.

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.

Eur Heart J. 2017; 38: 1119-1127View in Article Scopus (204) PubMed Crossref Google ScholarCody R.J. Haas G.J. Binkley P.F. et al.

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.

Circulation. 1992; 85: 504-509View in Article PubMed Crossref Google ScholarPousset F. Isnard R. Lechat P. et al.

Prognostic value of plasma endothelin-1 in patients with chronic heart failure.

Eur Heart J. 1997; 18: 254-258View in Article PubMed Crossref Google ScholarVachiery J.L. Delcroix M. Al-Hiti H. et al.

Macitentan in pulmonary hypertension due to left ventricular dysfunction.

Eur Respir J. 2018; 51View in Article Scopus (92) Crossref Google ScholarKalra P.R. Moon J.C. Coats A.J.

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?.

Int J Cardiol. 2002; 85: 195-197View in Article Scopus (266) PubMed Abstract Full Text Full Text PDF Google ScholarPacker M. McMurray J. Massie B.M. et al.

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.